Authors

• Gabriel Schnetzler (ORCID: https://orcid.org/0000-0003-4889-8596)
• María Vieito (ORCID: https://orcid.org/0000-0001-7531-343X)
• Oliver Edgar Bechter (ORCID: https://orcid.org/0000-0003-0667-3284)
• Florian Renner (ORCID: https://orcid.org/0000-0003-3326-0303)
• Elisa Cinato
• I. Moreno
• Nicole A. Kratochwil (ORCID: https://orcid.org/0000-0002-2149-4375)
• E. Fontana
• Nino Keshelava (ORCID: https://orcid.org/0009-0001-0978-3393)
• Christina Godfried Sie (ORCID: https://orcid.org/0000-0001-6377-4255)
• Nick Flinn
• David Dejardin (ORCID: https://orcid.org/0000-0001-8960-5345)
• Andreas Roller (ORCID: https://orcid.org/0000-0001-6335-0962)
• Catherine Han (ORCID: https://orcid.org/0000-0003-1016-3113)
• Martin Kornacker (ORCID: https://orcid.org/0000-0002-3502-928X)
• Piergiorgio Pettazzoni (ORCID: https://orcid.org/0000-0001-9039-2463)
• R. Plummer
• H. Prenen
• Ernesto Guarin
• Eduardo Castañón
• Tomi Fakolade
• Rikke Løvendahl Eefsen
• Martha Serrano-Serrano
• Reinhard Dummer
• Abiraj Keelara
• David J. Pinato
• Mahdi About

Institutions

• Roche (Switzerland) (CH)
• Universitat Autònoma de Barcelona (ES)
• Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
• Sarah Cannon Research Institute (GB)
• Auckland City Hospital (NZ)
• Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
• Hammersmith Hospital (GB)
• Gentofte Hospital (DK)
• University Hospital of Zurich (CH)
• Antwerp University Hospital (BE)
• Roche (United Kingdom) (GB)
• HM Hospitales (ES)
• Clinica Universidad de Navarra (ES)
• Hospital Universitario HM Sanchinarro (ES)
• Imperial College London (GB)

Publication Details

Journal

Journal of Clinical Oncology

Published

2026-03-27

DOI

https://doi.org/10.1200/jco-25-02444

Primary Topic

Melanoma and MAPK Pathways

Type

article

Field-Weighted Citation Impact

0.00